BioMarin Pharmaceutical Inc. (FRA:BM8)

BioMarin Pharmaceutical Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,094	12,100	16,432	17,997	14,263	13,013
Market Cap Growth	-24.30%	-26.36%	-8.70%	26.18%	9.60%	-3.84%
Enterprise Value	8,343	11,783	16,404	17,826	14,270	13,013
Last Close Price	47.71	64.02	87.66	95.65	78.98	70.13
PE Ratio	20.50	29.35	108.34	135.87	-	18.64
PS Ratio	3.45	4.39	7.51	9.18	8.79	8.56
PB Ratio	1.76	2.21	3.67	4.18	3.80	3.88
P/TBV Ratio	1.90	2.44	4.10	4.73	4.41	4.56
P/FCF Ratio	12.82	25.70	290.28	350.06	77.63	-
P/OCF Ratio	11.67	21.87	114.04	109.34	53.26	186.47
EV/Sales Ratio	3.13	4.28	7.50	9.09	8.79	8.56
EV/EBITDA Ratio	12.00	18.30	62.49	121.62	481.22	1186.81
EV/EBIT Ratio	13.63	21.40	97.60	348.42	-	-
EV/FCF Ratio	11.76	25.03	289.80	346.74	77.67	-
Debt / Equity Ratio	0.10	0.11	0.23	0.24	0.26	0.28
Debt / EBITDA Ratio	0.75	0.93	3.73	6.58	23.56	43.10
Debt / FCF Ratio	0.73	1.30	18.12	20.38	5.38	-
Asset Turnover	0.43	0.41	0.37	0.34	0.31	0.35
Inventory Turnover	0.45	0.50	0.53	0.60	1.49	1.67
Quick Ratio	2.84	2.96	1.45	2.98	2.54	3.07
Current Ratio	4.83	5.33	2.51	4.67	4.16	4.76
Return on Equity (ROE)	9.07%	8.05%	3.51%	3.19%	-1.53%	23.63%
Return on Assets (ROA)	6.15%	5.15%	1.76%	0.55%	-0.78%	-1.09%
Return on Capital (ROIC)	7.01%	5.76%	1.97%	0.61%	-0.87%	-1.24%
Return on Capital Employed (ROCE)	10.40%	8.90%	3.30%	0.90%	-1.40%	-1.70%
Earnings Yield	4.88%	3.41%	0.92%	0.74%	-0.40%	5.37%
FCF Yield	7.80%	3.89%	0.34%	0.29%	1.29%	-0.18%
Buyback Yield / Dilution	-2.10%	-2.67%	-1.39%	-3.34%	4.61%	-7.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.